CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Quest Diagnostics to Add Roche's Elecsys to Alzheimer's Biomarker Test Portfolio

PartnershipElecsysPositive
AI Analysis

Summary

Quest Diagnostics has added Roche's Elecsys to its Alzheimer's biomarker test portfolio, expanding diagnostic offerings for neurological conditions.

Importance:5/10
Sentiment:
0.30
diagnosticsAlzheimer'sbiomarkerspartnershipin-vitro diagnostics
Related Companies

Read the original article

Published by yahoo_finance on August 24, 2026 12:24 PM

Read Original